ask="266.00"
ask_size="300"
average_daily_volume="379490"
bid="20.69"
bid_size="2000"
book_value="3.21"
change="+0.23"
change_from_200_day_moving_average="7.45"
change_from_50_day_moving_average="2.32"
change_from_52_week_high="-2.29"
change_From_52_week_low="15.92"
change_in_percent="+1.08%"
close="21.46"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.47"
ex_dividend_date="N/A"
float_shares="7150000"
high="22.21"
high_52_weeks="23.75"
last_trade_date="2/21/2017"
last_trade_price="21.46"
last_trade_size="2899"
last_trade_time="4:00pm"
low="21.26"
low_52_weeks="5.54"
market_capitalization="213.59M"
moving_average_200_day="14.01"
moving_average_50_day="19.14"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.43"
open="21.60"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+53.21%"
percent_change_from_50_day_moving_average="+12.10%"
percent_change_from_52_week_high="-9.64%"
percent_change_from_52_week_low="+287.36%"
previous_close="21.23"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.62"
price_per_sales="3738.27"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="3.02"
stock_exchange="NGM"
symbol="ZYNE"
volume="281563"
weeks_range_52="5.54 - 23.75"
